Join
Live feed
·
INSIDERFilingvia Quantisnow
Cue Biopharma Inc. logo

SEC Form 4: Suri Anish bought $11,040 worth of shares (4,000 units at $2.76), increasing direct ownership by 3% to 135,638 units

ByQuantisnow·Wall Street's wire, on your screen.
CUE· Cue Biopharma Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CUE (Cue Biopharma Inc.) and more on Quantisnow.